GlassScriptPhysician profile
Gilberto G Concepcion
NPI 1679572879
$36,384.60
in general payments reported to CMS, 2019-2025
36 companies · $1,883 in 2025
The $1,883 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,387 · 2021: $2,829 · 2022: $4,940 · 2023: $9,213 · 2024: $4,528 · 2025: $1,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,925 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,925.22 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $9,647.21 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $7,006.71 | 2019-2020 | |
| Biotronik INC. | $4,454.41 | 2019-2023 | Biomonitor, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $3,707.04 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Boston Scientific Corporation | $3,583.41 | 2019-2025 | Avvigo Guidance System, Sentinel, Emerge Push |
| Medtronic, INC. | $1,579.71 | 2022-2025 | Cobalt Dr Mri Surescan, Pulseselect, Turbohawk |
| Novartis Pharmaceuticals Corporation | $1,511.23 | 2019-2025 | |
| Osprey Medical INC | $564.27 | 2021 | |
| Surmodics, INC. | $468.07 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $466.90 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $390.61 | 2019-2024 | Brilinta, Farxiga |
| Bard Peripheral Vascular, INC. | $384.15 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $277.19 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $254.34 | 2019-2025 | Lifevest |
| Abiomed | $243.31 | 2021-2025 | Impella |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $220.14 | 2021 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $174.45 | 2019 | |
| Biosense Webster, INC. | $144.00 | 2024 | Carto 3 |
| Esperion Therapeutics, INC. | $143.86 | 2021 | |
| Inari Medical, INC. | $131.03 | 2022 | |
| Pfizer INC. | $125.00 | 2021-2025 | |
| Venclose INC. | $124.39 | 2020 | |
| Penumbra, INC. | $120.00 | 2020 | |
| Argon Medical Devices, INC. | $112.88 | 2024 | Clot Management |
| Lexicon Pharmaceuticals, INC. | $86.88 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $82.51 | 2023-2024 | Assure Wcd |
| Philips North America LLC | $59.69 | 2019-2023 | |
| Ge Healthcare | $56.91 | 2022 | |
| Becton, Dickinson and Company | $51.21 | 2024 | Venclose Maven Catheter |
| Sanofi-Aventis U.S. LLC | $44.37 | 2024 | |
| Novo Nordisk INC | $42.86 | 2024 | |
| Impulse Dynamics (USA) INC. | $39.03 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $23.48 | 2025 | Eliquis |
| Kiniksa Pharmaceuticals, LTD. | $22.88 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.23 | 2022 | |
| Scpharmaceuticals INC. | $18.24 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilberto Concepcion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.